Impact of bariatric surgery on cardiovascular and musculoskeletal morbidity

57

Productos » COVIDIEN » Paquetes Cirugía de Obesidad » Impact of bariatric surgery on cardiovascular and musculoskeletal morbidity

Publicado el: 2010-04-03

Paquetes Cirugía de Obesidad

 Surg Obes Relat Dis. 2006 Nov-Dec;2(6):587-91. Epub 2006 Sep 22.

Impact of bariatric surgery on cardiovascular and musculoskeletal morbidity.

Sampalis JS, Sampalis F, Christou N.

Department of Surgery, McGill University Health Centre, Montreal, Quebec, Canada. jsampalis@jssresearch.com

BACKGROUND: Obesity is currently recognized as a global epidemic. According to recent statistics, the prevalence of obesity increased from 13.8% of the Canadian population in 1978-1979 to 23.1% in 2004, and the prevalence of morbid obesity increased from .9% in 1978-1979 to 2.7% in 2004. Obesity is a known risk factor for highly prevalent chronic diseases, including cardiovascular and musculoskeletal disorders. The objective of the study was to assess the impact of bariatric surgery on cardiovascular and musculoskeletal morbidity. METHODS: This was an observational study that compared a cohort of 1035 morbidly obese patients treated with bariatric surgery at the Centre for Bariatric Surgery, McGill University Health Centre with a matched cohort of 5746 morbidly obese nonsurgically treated controls. Data were obtained from the Quebec provincial health insurance database (Régie de l'Assurance Maladie du Québec). Morbidity indicators included diagnoses or treatment for cardiovascular or musculoskeletal disorders. RESULTS: Patients who underwent bariatric surgery had a significant 62% mean reduction in excess weight and 32% mean reduction in body mass index (P < .001). Compared with the matched controls, patients who had undergone bariatric surgery had significantly lower rates of diagnoses and treatments related to cardiovascular and musculoskeletal conditions. CONCLUSIONS: These results indicate that bariatric surgery is effective in reducing weight and significantly reduces the risk of cardiovascular and musculoskeletal morbidity.

PMID: 16996318 [PubMed - indexed for MEDLINE]